TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway.
about
The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic miceMouse models of intestinal cancerColorectal cancer models for novel drug discoveryAnimal models of colorectal cancerIn vivo fluorescence-based endoscopic detection of colon dysplasia in the mouse using a novel peptide probeThe somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cellsMultiple components of PKA and TGF-β pathways are mutated in pseudomyxoma peritoneiSynthetic lethal therapy for KRAS mutant non-small-cell lung carcinoma with nanoparticle-mediated CDK4 siRNA deliveryPrediction and testing of biological networks underlying intestinal cancerMusashi-1 promotes a cancer stem cell lineage and chemoresistance in colorectal cancer cells.Genetic and Chemical Models of Colorectal Cancer in Mice.Krüppel-like factor 5 is a crucial mediator of intestinal tumorigenesis in mice harboring combined ApcMin and KRASV12 mutations.A reciprocal role of prostate cancer on stromal DNA damage.Animal models of gastrointestinal and liver diseases. New mouse models for studying dietary prevention of colorectal cancerTemporal dissection of K-ras(G12D) mutant in vitro and in vivo using a regulatable K-ras(G12D) mouse alleleHypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosisThe utility of Apc-mutant rats in modeling human colon cancer.Concomitant Notch activation and p53 deletion trigger epithelial-to-mesenchymal transition and metastasis in mouse gut.Vicious cycle of TGF-β signaling in tumor progression and metastasis.PETALS: Proteomic Evaluation and Topological Analysis of a mutated Locus' Signaling.MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancer.β-Catenin and K-RAS synergize to form primitive renal epithelial tumors with features of epithelial Wilms' tumors.The landscape of somatic chromosomal copy number aberrations in GEM models of prostate carcinoma.Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.Pathology of rodent models of intestinal cancer: progress report and recommendationsChallenges and advances in mouse modeling for human pancreatic tumorigenesis and metastasisThe crosstalk of RAS with the TGF-β family during carcinoma progression and its implications for targeted cancer therapy.Anti-fibrogenic strategies and the regression of fibrosis.Regulation of homeostasis and oncogenesis in the intestinal epithelium by Ras.Mysteries of TGF-β Paradox in Benign and Malignant Cells.Role of MTA1 in head and neck cancers.Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool.Biased competition between Lgr5 intestinal stem cells driven by oncogenic mutation induces clonal expansion.A recellularized human colon model identifies cancer driver genes.TGF-β signaling in liver and gastrointestinal cancersTGFβ engages MEK/ERK to differentially regulate benign and malignant pancreas cell functionInactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivoNo back seat for a progression event-K-RAS as a therapeutic target in CRC.Differentiated intestinal epithelial cells express high levels of TGF-β receptors and exhibit increased sensitivity to growth inhibition.Three-dimensionally specific inhibition of DNA repair-related genes by activated KRAS in colon crypt model.
P2860
Q24623318-56B12402-43DC-43D7-8072-9756925297F0Q26785563-DCA4423D-5BC8-47DA-AE65-EB051DD77036Q26795724-F7FA316A-541D-4898-9E47-83FB0817F758Q27009170-4E473959-3A19-4D62-838A-F3BC05EBCF39Q27350293-CDF24D99-542E-4F5A-B528-1B61A0CB4E9DQ28484664-EC286F53-C3F4-4343-AF2A-5DBBAA886513Q33584714-8A48D414-EC64-466A-8CD6-A89BFFEEBA51Q33587012-0A0CB2C0-2A62-4E31-8A26-CADCCF9C0740Q33687092-10C564CB-2E8A-48DF-A2DF-87BC4DAB4E6DQ33708609-D46320DF-8461-41C2-8D24-E877B1025A8BQ33771627-910DD6DA-C5CB-41C3-8B2A-B91419C62F1EQ33797492-92C5AC00-E46A-4C05-9A85-8B57E4006775Q34000472-835EBD1F-61E7-4484-B42B-E0430BB755D9Q34001641-76DA4FE1-9AB9-492A-AF42-0494E560F3A4Q34273969-31BEB4AF-6708-490B-A28C-A4D204BD7AFDQ34372543-0CF60FCF-92B7-4C99-A42D-63F91964B452Q34424145-CDC3D3F2-9D50-4731-9B04-007B8DCA8EF6Q34427267-4C78735A-A32F-4CC6-B96A-A1BD6FF4E3F0Q34448186-33D13AA5-7401-47A6-BB9C-FC0D3899B79CQ34468610-20C4C510-36E7-4017-8E35-10EC07970F3FQ35005275-F18472E2-19A7-4D2C-8656-F7F78E081DE2Q35679310-7E8A617A-3BFE-4DE9-BF7B-A9EDFE14664DQ35923532-D7CAB21D-C4DD-420B-9E3C-CD498F2B632AQ36190022-8133DB3F-5ACD-4299-8BD4-26B8BA3A5C20Q36865701-2AC753A6-BE25-4584-9699-C10D65EB1260Q37411831-5284E8F8-25AD-4536-B43D-8A3C8BF00FE5Q37780777-595AB0A8-9404-428E-8790-49FB9D29A7D7Q37865870-CFF9A591-62F9-4EC6-A3CD-47F1FC04C35DQ37899488-3554CBD6-2D1C-4557-9227-95F62DE451EDQ38214771-52A88DBE-399F-4C6E-991D-23B76D622B55Q38264091-13ABE0A0-A63D-490E-BA05-2A3AFC78ACA8Q38271066-E08915B0-B5DB-4BCC-8018-F2803EBB68F2Q38710117-9707D3E9-F693-4723-9EDD-DF289D9A26E3Q38758881-B305AB69-AD7F-4F91-AF25-3CE8039791E9Q38796618-45424992-68A8-423F-AF3D-DB97AF15AF9BQ38860980-B1B212D2-5618-4240-81A2-40F3D0B76988Q39162939-0241C49A-9753-4BA9-AD30-22116AFDC1D4Q39185370-19A37522-5335-4BDB-85F3-621B07BC9194Q39433062-0592B165-08CF-4649-9DE4-88CED14032A5Q39705991-B988AE1E-4650-4802-8546-F1EEDDCE693A
P2860
TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
TGF-beta receptor inactivation ...... a-catenin-independent pathway.
@en
TGF-beta receptor inactivation ...... a-catenin-independent pathway.
@nl
type
label
TGF-beta receptor inactivation ...... a-catenin-independent pathway.
@en
TGF-beta receptor inactivation ...... a-catenin-independent pathway.
@nl
prefLabel
TGF-beta receptor inactivation ...... a-catenin-independent pathway.
@en
TGF-beta receptor inactivation ...... a-catenin-independent pathway.
@nl
P2093
P2860
P1433
P1476
TGF-beta receptor inactivation ...... a-catenin-independent pathway.
@en
P2093
Andres Rojas
Cornelia M Ulrich
Karen D Tsuchiya
M Kay Washington
Nina M Munoz
Patty Trobridge
Senji Shirasawa
Sue Knoblaugh
Takehiko Sasazuki
William M Grady
P2860
P304
P356
10.1053/J.GASTRO.2009.01.066
P407
P577
2009-02-04T00:00:00Z